The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
American Society of Clinical Oncology
American Society of Clinical Oncology
Hoffmann-La Roche
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Hoffmann-La Roche
Incyte Corporation
Royal Marsden NHS Foundation Trust
Forward Pharmaceuticals Co., Ltd.
Weill Medical College of Cornell University
Avenzo Therapeutics, Inc.
Northwestern University
Criterium, Inc.
Abramson Cancer Center at Penn Medicine
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Lebanese University
National Taiwan University Hospital